Skip to main content

CORRECTION article

Front. Mol. Biosci., 23 April 2024
Sec. Molecular Diagnostics and Therapeutics
Volume 11 - 2024 | https://doi.org/10.3389/fmolb.2024.1413164

Corrigendum: MicroRNAs regulating tumor immune response in the prediction of the outcome in patients with breast cancer

This article is a correction to:

  1. MicroRNAs Regulating Tumor Immune Response in the Prediction of the Outcome in Patients With Breast Cancer

    1. Read original article
Konstantina Thomopoulou,&#x;Konstantina Thomopoulou1,2†Chara Papadaki&#x;Chara Papadaki2†Alexia MonastiriotiAlexia Monastirioti2George KoronakisGeorge Koronakis1Anastasia MalaAnastasia Mala1Despoina KalapanidaDespoina Kalapanida1Dimitrios Mavroudis,Dimitrios Mavroudis1,2Sofia Agelaki, Sofia Agelaki1,2*
  • 1Department of Medical Oncology, University General Hospital, Crete, Heraklion, Greece
  • 2Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece

A Corrigendum on
MicroRNAs regulating tumor immune response in the prediction of the outcome in patients with breast cancer

by Thomopoulou K, Papadaki C, Monastirioti A, Koronakis G, Mala A, Kalapanida D, Mavroudis D and Agelaki S (2021). Front. Mol. Biosci. 8:668534. doi: 10.3389/fmolb.2021.668534

In the published article, there was an error regarding the Affiliations for Konstantina Thomopoulou. As well as having affiliation 1, they should also have “2 Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: circulating miRNAs, early breast cancer, metastatic breast cancer, immune response, prognosis

Citation: Thomopoulou K, Papadaki C, Monastirioti A, Koronakis G, Mala A, Kalapanida D, Mavroudis D and Agelaki S (2024) Corrigendum: MicroRNAs regulating tumor immune response in the prediction of the outcome in patients with breast cancer. Front. Mol. Biosci. 11:1413164. doi: 10.3389/fmolb.2024.1413164

Received: 06 April 2024; Accepted: 09 April 2024;
Published: 23 April 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Thomopoulou, Papadaki, Monastirioti, Koronakis, Mala, Kalapanida, Mavroudis and Agelaki. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Sofia Agelaki, YWdlbGFraXNvZmlhQGdtYWlsLmNvbQ==

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.